
Rami Manochakian: Thank you to the leadership of ASCO for addressing the ABIM MOC issue/requirements
Rami Manochakian, Associate Professor and HemOnc Fellowship Director at Mayo Clinic, shared on Twitter,
“THANK YOU to the leadership of the American Society of Clinical Oncology (ASCO) for addressing the ABIM MOC issue/requirements.
Grateful to OUR GREAT SOCIETY that truly represents the Oncology Community & honored to be an active member.
Statement👇🏼”
Source: Rami Manochakian / Twitter
Text below,
“Dear Colleagues,
Many physicians have raised concerns about the current Maintenance of Certification (MOC) requirements administered by the American Board of Internal Medicine (ABIM).
ASCO members are no exception, and we have heard widespread concern that the program, including the current Longitudinal Knowledge Assessment, is not supporting relevant learning and can be time-consuming and expensive relative to its perceived benefits.
The Society Board, recognizing these challenges, wishes to collaboratively help identify a more effective approach. Following robust discussions at our most recent Board meeting, we are writing to share an update on ASCO’s next steps aimed at addressing our shared concerns:
- We are establishing a new Board-level task force that will formally assess member experience and needs, and then help develop and vet potential solutions that achieve our goal of supporting and demonstrating continuous learning in oncology.
- We will survey our U.S. medical oncologist members to better understand all of your views of certification, maintenance of certification, and to gain recommendations for solutions. Please look for the survey soon – we want and need your input to generate evidence-based options.
- We will collaborate with all stakeholders to determine solutions for medical oncologists to maintain certification with the focus on learning rather than testing.
As a professional society responsible for supporting and representing our members in our shared quest for high quality cancer care, ASCO will bring extensive knowledge and experience to inform potential solutions to the current maintenance of certification process on your behalf. We will continue to seek input from our community, including ABIM, and we will keep you informed about our progress based on the efforts outlined above.
Now more than ever, continuous learning is essential given the rapid pace of scientific advances that have led so many new treatment options for patients with cancer. We recognize that each of you is dedicated to continuing education to deliver the best possible care to your patients, and we want to help patients have confidence that their physicians are on the leading edge of knowledge and practice.
We thank you for your engagement and will continue communicate with you as ASCO works to resolve this critical issue for the oncology community. Again, we encourage you to share your input through the upcoming survey or MOC@asco.org.
Sincerely yours,
Clifford Hudis, MD, FACP, FASCO
CEO
Lynn Mara Schuchter, MD, FASCO
President, 2023 – 2024
Eric P. Winer, MD, FASCO
Chair, Board of Directors, 2023 – 2024″
-
Dec 10, 2023, 17:20 | BlogDaniel Blanco: Day 1 of the 2023 St. Jude Global Alliance Convening
-
Dec 10, 2023, 16:59 | InsightYüksel Ürün: MFS continues to be a reliable predictor for overall survival
-
Dec 10, 2023, 18:12The Cancer Research Interns (CRI) Summer Program is now accepting applications! - Train at NCI
-
Dec 10, 2023, 18:08Apply for the Basic Research in Cancer Health Disparities Program - NCI Center to Reduce Cancer Health Disparities (CRCHD)
-
Dec 10, 2023, 18:01Giselle Sholler: Our research that led to the FDA-Oncologic Drugs Advisory Committee 70% approval for moving Difluoromethylornithine forward
-
Dec 10, 2023, 16:59Yüksel Ürün: MFS continues to be a reliable predictor for overall survival
-
Dec 10, 2023, 12:03Eleonora Teplinsky: The POSITIVE Trial SABCS23 updates are so important to help with oncofertility counseling
-
Dec 10, 2023, 16:53Matteo Lambertini: December 7, 2023 …a day to remember
-
Dec 8, 2023, 16:33Big thank you to Dr. Rucha Kiran Patil for sharing their experiences and learnings on writing abstracts and poster presentations - Novo Nordisk Haemophilia Foundation
-
Dec 6, 2023, 14:57Tracy Gosselin: Jennifer Petruno Receives DAISY Award for Extraordinary Nurses
-
Dec 3, 2023, 16:34Tedros Adhanom Ghebreyesus: Grateful to Namibia’s Prime Minister Saara Kuugongelwa-Amadhila for her commitment to health
-
Dec 2, 2023, 18:08100 Influential Celebrities in Oncology: The 2023 Edition – Part 5
-
Dec 10, 2023, 05:08Global Summit on War and Cancer: Agenda
-
Dec 4, 2023, 16:26SIOP 2023 by Numbers! - International Society of Paediatric Oncology
-
Dec 2, 2023, 16:43In our recent survey, nearly 1,700 ASCO members shared feedback on the ABIM MOC requirements - ASCO
-
Nov 28, 2023, 17:34The International Association of Cancer Registries annual conference - IARC
-
Nov 26, 2023, 18:05Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
Dec 10, 2023, 17:39Dr. Salami is the winner of the American Urological Association’s prestigious Gold Cystoscope Award - YUO
-
Dec 10, 2023, 17:26Mark Awad was honored by GO2 for Lung Cancer at the 18th Annual Simply the Best Gala - Dana-Farber Cancer Institute
-
Dec 9, 2023, 17:00Wafik S. El-Deiry: Honored to share the news of my election as the Chair of the WIN Consortium in Personalized Cancer Medicine
-
Dec 8, 2023, 17:54Dana-Farber News congratulates Sara Tolaney on receiving the Susan G. Komen 2023 Rising Star Researcher Award
-
Dec 8, 2023, 17:35Timothy M. Pawlik: Excited to announce Samilia Obeng-Gyasi as THE inaugural Endowed Surgical Professor in Health Equity